Skip to content

Mental Health After Dexmedetomidine for Electrical Storm

Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm: Outpatient Follow-up of Mental Health INDices (SDATE OF MIND)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07368062
Enrollment
70
Registered
2026-01-26
Start date
2025-03-15
Completion date
2028-06-01
Last updated
2026-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental Health

Keywords

Electrical storm, Ventricular tachycardia, Dexmedetomidine, Mental health

Brief summary

The goal of the research study is to measure mental health and quality of life indices of individuals treated for electrical storm (ES). The consequences of being admitted to an intensive care unit (ICU) with electrical storm as well as the treatments patients would have received, are currently not well understood. Understanding the mental health burden of these treatments among survivors can provide insights into how to improve care. This is a study consisting of patients who participated in the SEDATE trial (dexmedetomidine vs usual standard of care to treat ES in the ICU). Patients who consent to participate in this study will be asked to complete a set of questionnaires 3-6 months after their ICU admission. The purpose of the questionnaires is to measure indices of mental health and health-related quality of life. Each questionnaire will take about 5-15 minutes to complete. If patients have a scheduled follow-up at the University of Ottawa Heart Institute, a member of the research team will meet with them during their clinic visit to complete the questionnaires. Otherwise, they can be completed over the telephone.

Interventions

DRUGDexmedetomidine

Dexmedetomidine infusion during ICU admission for electrical storm

DRUGPlacebo

Placebo (standard of care, no dexmedetomidine), for treatment of electrical storm while admitted to ICU

Sponsors

Ottawa Heart Institute Research Corporation
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients admitted to an intensive care unit with a diagnosis of electrical storm within the preceding 6 months * Previous participants in the SEDATE trial (NCT06281977)

Exclusion criteria

\- None

Design outcomes

Primary

MeasureTime frameDescription
Post-traumatic stress disorder symptomsAssessed 3-6 months after hospitalization for electrical stormPost-traumatic stress disorder (PTSD) checklist (PCL-5) score. Respondents are asked to rate the presence and severity of various symptoms in the preceding month on 5-point Likert scale. A higher score indicates worse symptoms. A cumulative cut-off score of 31-33 is usually considered indicative of probable PTSD

Secondary

MeasureTime frameDescription
Anxiety symptomsAssessed 3-6 months after hospitalization for electrical stormGeneral Anxiety Disorder 7-item (GAD-7). This is a screening tool for the presence and measure of the severity of anxiety symptoms. A higher score suggests more severe symptoms
Depression symptomsAssessed 3-6 months after hospitalization for electrical stormPatient Health Questionnaire-9 (PHQ-9). This is a screening tool for the presence and measure of the severity of depression symptoms. A higher score suggests more severe symptoms.
Anxiety/fear relating to implantable cardioverter-defibrillator shocksAssessed 3-6 months after hospitalization for electrical stormFlorida Shock Anxiety Scale (FSAS). This is a measure of patient anxiety/fear relating to implantable cardioverter-defibrillator shocks. A higher score suggests more shock-related anxiety
Quality of life measureAssessed 3-6 months after hospitalization for electrical stormQuality of life measurements, as obtained through use of the 36-Item Short Form Survey Instrument (SF-36), a validated questionnaire tool to measure health-related quality of life/health status across specific domains. A higher score indicates better self-reported health

Countries

Canada

Contacts

CONTACTF Daniel Ramirez, MD MSc FRCPC
dramirez@ottawaheart.ca1+ 613-696-7000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 2, 2026